prism software version 3.02 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
prism software version 3.02
Prism Software Version 3.02, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism%C2%AE+version+3%2E02+software/prism+software/pm39579523-69-37-41
Average 90 stars, based on 1 article reviews
Prism Software Version 3.02, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism%C2%AE+version+3%2E02+software/prism+software/pm39579523-69-37-41
Average 90 stars, based on 1 article reviews
prism software version 3.02 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Calcium Oxalate Monohydrate is Associated with Endothelial Cell Toxicity But Not with Reactive Oxygen Species Accumulation. Article Snippet: One characteristic of ethylene glycol overdose is a cardiopulmonary syndrome including hypertension and pulmonary edema with pathology indicating damage to the endothelium of heart, lung and brain vessels.. The mechanism of the cardiopulmonary toxicity is unknown, but has been linked with accumulation of the metabolite calcium oxalate monohydrate (COM) in the endothelium.. These studies have evaluated the hypothesis that COM or the oxalate ion produces endothelial damage in vitro and that damage is linked with induction of reactive oxygen species (ROS). Article Title: Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy. Article Snippet: Purpose To examine the role of phosphatase inhibition on anti-CD22, HB22.7-mediated lymphomacidal eVects.. Experimental design CD22 is a cell-surface molecule expressed on most B cell lymphomas (NHL).. HB22.7 is an anti-CD22 monoclonal antibody that binds a unique CD22epitope, blocks ligand binding, initiates signaling, and has demonstrated lymphomacidal activity. |